Skip to main content
. 2020 May 22;56(2):106024. doi: 10.1016/j.ijantimicag.2020.106024

Table 1.

Summary of the main extra-respiratory manifestations of patients with COVID-19.

Organ/system Symptoms/signs (reported prevalence of patients) References
Cardiac Acute cardiac injury (8–12%), heart failure (23–52%), arrhythmia (8.9–16.7%), shock, acute myocarditis, chest tightness [8,[7], [8], [9], [10], [11], [12], [13], [14]]
Gastrointestinal Anorexia (26.8%), diarrhoea (12.5%), nausea/vomiting (10.2%), abdominal pain/discomfort (9.2%) [[18], [19], [20],24,25,27,28]
Hepatic Abnormal aspartate aminotransferase or alanine aminotransferase values (16.1–53.1%) [8,10,[21], [22], [23], [24], [25], [26]]
Kidney Acute kidney injury (overall 0.5%; 2.9–23% in severe cases) [10,24,25]
Neurological Dizziness (16.8%), headache (13.1%), skeletal muscle injury (10.7%), impaired consciousness (7.5%), acute cerebrovascular disease (2.8%), ataxia (0.5%), seizures (0.5%), meningoencephalitis, Guillain–Barré syndrome [31], [32], [33], [34]
Olfactory and gustatory Hyposmia (5.1–20.4%), anosmia (79.6%), dysgeusia (8.5%), ageusia (1.7%) [24,25,39,40]
Ocular Acute conjunctivitis (31.6%) [44,45]
Cutaneous Erythematous rash (15.9%), hives rash (3.4%), vesicles (1.1%), acro-ischaemia, transient unilateral livedo reticularis [25,[49], [50], [51], [52]]
Haematological Lymphopenia (56.5%), thrombocytopenia (16.4–32.3%), coagulation disorders, thrombotic events, antiphospholipid antibody [53], [54], [55], [56], [57], [58], [59]